Sudarshan Pharma

{
  "main_header": {
    "sid": 1003813,
    "name": "Sudarshan Pharma",
    "stock_name": "Sudarshan Pharma",
    "full_name": "Sudarshan Pharma Industries Ltd",
    "name_url": "stocks-analysis/sudarshan-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "25.00",
    "chg": -1.28,
    "chgp": "-4.87%",
    "dir": -1,
    "prev_price": "26.28",
    "mcapval": "602.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543828,
    "symbol": "",
    "ind_name": "Specialty Chemicals",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE00TV01023",
    "curr_date": "Feb 10",
    "curr_time": "",
    "bse_nse_vol": 232000,
    "exc_status": "Active",
    "traded_date": "Feb 10, 2026",
    "traded_date_str": "2026 02 10",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sudarshan-pharma-1003813-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sudarshan Pharma Industries Ltd: Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-industries-ltd-technical-momentum-shifts-amid-mixed-market-signals-3829952",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SudarshanPharma_technicaldot_3829952.png",
        "date": "2026-02-10 08:07:26",
        "description": "Sudarshan Pharma Industries Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a strong weekly price surge of 3.43%, the stock’s longer-term performance remains subdued, prompting a detailed analysis of its technical indicators and market context."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-industries-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-3827968",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SudarshanPharma_technicaldot_3827968.png",
        "date": "2026-02-09 08:03:22",
        "description": "Sudarshan Pharma Industries Ltd has witnessed a notable shift in its technical momentum, with price action surging 10.00% in a single day to close at ₹25.41. Despite this sharp uptick, the stock remains under pressure over longer time frames, reflecting a complex interplay of technical indicators and market sentiment within the Specialty Chemicals sector."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sudarshan-pharma-industries-ltd-is-rated-sell-3820419",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SudarshanPharma_mojoScore_3820419.png",
        "date": "2026-02-04 10:10:04",
        "description": "Sudarshan Pharma Industries Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 February 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Are Sudarshan Pharma Industries Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-sudarshan-pharma-industries-ltd-latest-results-good-or-bad-3810138",
        "imagepath": "",
        "date": "2026-01-29 19:25:48",
        "description": "Sudarshan Pharma Industries Ltd's latest financial results for Q3 FY26 present a complex picture of growth tempered by margin pressures. The company reported a net profit of ₹4.36 crores, reflecting a year-on-year increase of 51.39%, while revenue reached ₹168.01 crores, marking a 45.26% rise compared to the same quarter last year. However, the operating margin, excluding other income, contracted to 6.47% from 10.14% in the previous year, indicating challenges in maintaining profitability amidst rising costs.\n\nFor the nine-month period ending December 2025, consolidated net profit was ₹12.58 crores, up 49.25% year-on-year, with revenue of ₹482.14 crores, which represents a 38.93% increase. Despite these positive growth metrics, the company's profitability margins have come under strain, with a profit after tax margin of 2.47% in Q3 FY26, down from 4.57% in the same quarter last year. This decline is attribu..."
      },
      {
        "title": "Sudarshan Pharma Q3 FY26: Growth Momentum Masks Rising Debt Burden",
        "link": "https://www.marketsmojo.com/news/result-analysis/sudarshan-pharma-q3-fy26-growth-momentum-masks-rising-debt-burden-3809526",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SudarshanPharma_quaterlyResult_3809526.png",
        "date": "2026-01-29 09:53:22",
        "description": "Sudarshan Pharma Industries Limited reported consolidated net profit of ₹4.36 crores for Q3 FY26, registering growth of 4.31% quarter-on-quarter and 51.39% year-on-year. The specialty chemicals manufacturer, with a market capitalisation of ₹468.32 crores, delivered robust revenue expansion of 45.26% YoY to ₹168.01 crores, though sequential momentum moderated with a marginal decline of 0.51% QoQ. The stock has plunged 54.89% over the past year, significantly underperforming both the Sensex and its sector peers, as investors grapple with concerns over elevated debt levels and compressed profitability metrics despite sustained topline growth."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sudarshan-pharma-industries-ltd-is-rated-sell-3803100",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SudarshanPharma_mojoScore_3803100.png",
        "date": "2026-01-24 10:10:03",
        "description": "Sudarshan Pharma Industries Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 October 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 24 January 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "When is the next results date for Sudarshan Pharma Industries Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-sudarshan-pharma-industries-ltd-3802606",
        "imagepath": "",
        "date": "2026-01-23 23:16:39",
        "description": "The next results date for Sudarshan Pharma Industries Ltd is scheduled for January 28, 2026...."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd Faces Bearish Momentum Amid Technical Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-industries-ltd-faces-bearish-momentum-amid-technical-downturn-3784001",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SudarshanPharma_technicaldot_3784001.png",
        "date": "2026-01-07 08:28:16",
        "description": "Sudarshan Pharma Industries Ltd, a key player in the specialty chemicals sector, has experienced a notable shift in price momentum, with technical indicators signalling a bearish trend. The stock’s recent performance, combined with deteriorating moving averages and mixed signals from momentum oscillators, suggests mounting pressure on the share price amid broader market challenges."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sudarshan-pharma-industries-ltd-is-rated-sell-3778874",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SudarshanPharma_mojoScore_3778874.png",
        "date": "2026-01-02 10:10:03",
        "description": "Sudarshan Pharma Industries Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      }
    ],
    "total": 116,
    "sid": "1003813",
    "stock_news_url": "https://www.marketsmojo.com/news/sudarshan-pharma-industries-1003813"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "31-Jan-2026",
      "details": "Interms of Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 we submit the Investor Presentation of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "30-Jan-2026",
      "details": "Please find enclosed herewith the newspaper advertisement for the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31/December/2025.",
      "source": "BSE"
    },
    {
      "caption": "Financial Results For The Quarter And Nine Months Ended 31-12-2025",
      "datetime": "28-Jan-2026",
      "details": "Pursuant to Regulation 33 of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 please find attached the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended 31-12-2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sudarshan Pharma Industries Ltd has declared <strong>3%</strong> dividend, ex-date: 25 Aug 23",
          "dt": "2023-08-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sudarshan Pharma Industries Ltd has announced <strong>1:10</strong> stock split, ex-date: 22 Nov 24",
          "dt": "2024-11-22",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sudarshan Pharma Industries Ltd: Technical Momentum Shifts Amid Mixed Market Signals

2026-02-10 08:07:26

Sudarshan Pharma Industries Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a strong weekly price surge of 3.43%, the stock’s longer-term performance remains subdued, prompting a detailed analysis of its technical indicators and market context.

Read full news article

Sudarshan Pharma Industries Ltd Sees Mixed Technical Signals Amid Price Momentum Shift

2026-02-09 08:03:22

Sudarshan Pharma Industries Ltd has witnessed a notable shift in its technical momentum, with price action surging 10.00% in a single day to close at ₹25.41. Despite this sharp uptick, the stock remains under pressure over longer time frames, reflecting a complex interplay of technical indicators and market sentiment within the Specialty Chemicals sector.

Read full news article

Sudarshan Pharma Industries Ltd is Rated Sell

2026-02-04 10:10:04

Sudarshan Pharma Industries Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 February 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Are Sudarshan Pharma Industries Ltd latest results good or bad?

2026-01-29 19:25:48

Sudarshan Pharma Industries Ltd's latest financial results for Q3 FY26 present a complex picture of growth tempered by margin pressures. The company reported a net profit of ₹4.36 crores, reflecting a year-on-year increase of 51.39%, while revenue reached ₹168.01 crores, marking a 45.26% rise compared to the same quarter last year. However, the operating margin, excluding other income, contracted to 6.47% from 10.14% in the previous year, indicating challenges in maintaining profitability amidst rising costs. For the nine-month period ending December 2025, consolidated net profit was ₹12.58 crores, up 49.25% year-on-year, with revenue of ₹482.14 crores, which represents a 38.93% increase. Despite these positive growth metrics, the company's profitability margins have come under strain, with a profit after tax margin of 2.47% in Q3 FY26, down from 4.57% in the same quarter last year. This decline is attribu...

Read full news article

Sudarshan Pharma Q3 FY26: Growth Momentum Masks Rising Debt Burden

2026-01-29 09:53:22

Sudarshan Pharma Industries Limited reported consolidated net profit of ₹4.36 crores for Q3 FY26, registering growth of 4.31% quarter-on-quarter and 51.39% year-on-year. The specialty chemicals manufacturer, with a market capitalisation of ₹468.32 crores, delivered robust revenue expansion of 45.26% YoY to ₹168.01 crores, though sequential momentum moderated with a marginal decline of 0.51% QoQ. The stock has plunged 54.89% over the past year, significantly underperforming both the Sensex and its sector peers, as investors grapple with concerns over elevated debt levels and compressed profitability metrics despite sustained topline growth.

Read full news article

Sudarshan Pharma Industries Ltd is Rated Sell

2026-01-24 10:10:03

Sudarshan Pharma Industries Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 October 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 24 January 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

When is the next results date for Sudarshan Pharma Industries Ltd?

2026-01-23 23:16:39

The next results date for Sudarshan Pharma Industries Ltd is scheduled for January 28, 2026....

Read full news article

Sudarshan Pharma Industries Ltd Faces Bearish Momentum Amid Technical Downturn

2026-01-07 08:28:16

Sudarshan Pharma Industries Ltd, a key player in the specialty chemicals sector, has experienced a notable shift in price momentum, with technical indicators signalling a bearish trend. The stock’s recent performance, combined with deteriorating moving averages and mixed signals from momentum oscillators, suggests mounting pressure on the share price amid broader market challenges.

Read full news article

Sudarshan Pharma Industries Ltd is Rated Sell

2026-01-02 10:10:03

Sudarshan Pharma Industries Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

View All News